Ratings by Deutsche Bank (Emmanuel Papadakis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/10/2026 | argenx SE | ARGX | Upgrade | Buy (Hold) |
740.40 (910.71) |
23% | Details | |
| 9/13/2024 | AstraZeneca | AZN | Downgrade | Sell (Hold) |
80.53 (92.77) |
15.2% | Details | |
| 9/2/2024 | CureVac | CVAC | Maintain | Hold (N/A) |
|
Details | ||
| 8/7/2024 | BioNTech | BNTX | Upgrade | Buy (Hold) |
78.36 (91.83) |
17.19% | Details | |
| 8/7/2024 | Moderna | MRNA | Upgrade | Hold (Sell) |
83.75 (60.82) |
-27.38% | Details | |
| 7/2/2024 | Alvotech SA | ALVO | Maintain | Hold (N/A) |
|
Details | ||
| 5/9/2024 | Moderna | MRNA | Maintain | Sell (N/A) |
|
Details | ||
| 2/8/2024 | AstraZeneca | AZN | Downgrade | Hold (Buy) |
66.55 (80.53) |
21.01% | Details | |
| 12/20/2023 | argenx SE | ARGX | Downgrade | Hold (Buy) |
455.48 (740.40) |
62.55% | Details | |
| 11/2/2023 | Moderna | MRNA | Downgrade | Hold (Sell) |
76.20 (83.75) |
9.91% | Details | |
| 8/3/2023 | Moderna | MRNA | Downgrade | Hold (Buy) |
110.22 (60.82) |
-44.82% | Details | |
| 5/17/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 4/24/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/7/2023 | Alvotech SA | ALVO | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2022 | CureVac | CVAC | Maintain | Hold (N/A) |
|
Details | ||
| 11/23/2022 | Alvotech SA | ALVO | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2022 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Moderna | MRNA | Upgrade | Buy (N/A) |
130.08 (60.82) |
-53.24% | Details | |
| 7/1/2022 | Alvotech SA | ALVO | New Coverage | Hold (N/A) |
8.46 (7.88) |
-6.86% | Details | |
| 3/7/2022 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 1/26/2022 | Moderna | MRNA | Upgrade | Hold (Sell) |
157.30 (60.82) |
-61.34% | Details | |
| 12/17/2021 | Novo Nordisk | NVO | Downgrade | Hold (Buy) |
117.08 (46.37) |
-60.39% | Details |
